Lipofilling as an Adjuvant Therapy for Postburn Grafted Hand: Functional and Aesthetic Outcome.
نویسندگان
چکیده
منابع مشابه
Opioid dependence and substitution therapy: thymoquinone as potential novel supplement therapy for better outcome for methadone maintenance therapy substitution therapy
Methadone is widely being used for opioid substitution therapy. However, the administration of methadone to opioid dependent individual is frequently accompanied by withdrawal syndrome and chemical dependency develops. Other than that, it is also difficult to retain patients in the treatment programme making their retention rates are decreasing over time. This article is written to higlights th...
متن کاملnano-rods zno as an efficient catalyst for the synthesis of chromene phosphonates, direct amidation and formylation of amines
چکیده ندارد.
Phytochemicals as an adjuvant in leukemia therapy
Aberrant production of immature white blood cells leads to the onset of leukemia. The process of leukemogenesis involves alterations in expressions of various genes and their associated signalling pathways. Existing treatment protocols for leukemia therapy may be quite effective but they pose serious adverse effects on the individual. Therefore, newer means need to be explored which may help to...
متن کاملP159: The Efficacy of Homeopathic Remedies as an Adjuvant Therapy in Patients with Social Phobia
Social phobia is an anxiety disorder characterized by heightened fear and avoidance of one or more social or performance situations, including public speaking, meeting new people, eating or writing in front of others and attending social meetings. People with social phobia are typically anxious about the possibility that others will evaluate them negatively and/or notice symptoms of their anxie...
متن کاملFractionated Stereotactic Radiotherapy as an Adjuvant Therapy for Pituitary Adenomas
Surgery is first-line therapy for functioning pituitary adenomas (FPAs) and non-functioning pituitary macroadenomas (NFPAs) apart from prolactinomas. About 30% of NFPAs recur within five to 10 years and up to 60% of FPAs are still biochemically active after surgery. Somatostatin analogues and/or the growth hormone (GH)-receptor antagonist pegvisomant are often needed to achieve disease control ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Al-Azhar International Medical Journal
سال: 2021
ISSN: 2682-339X
DOI: 10.21608/aimj.2021.63707.1421